Shenzhen Salubris Pharmaceuticals Co., Ltd.
Clinical trials sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd., explained in plain language.
-
New injection aims to tame high cholesterol
Disease control CompletedThis study tested a new injectable drug called SAL003 for lowering high cholesterol. It involved 618 Chinese adults who were not taking other cholesterol medications. For the first 12 weeks, some received the drug and others received a placebo injection every 4 weeks, followed by…
Phase: PHASE3 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New injection aims to tackle stubborn high cholesterol
Disease control CompletedThis study tested whether adding a new injectable drug called SAL003 to standard cholesterol pills (atorvastatin) could better lower 'bad' cholesterol (LDL-C) in adults with high cholesterol. It involved 214 participants and compared the effects of the new injection to a placebo …
Phase: PHASE2 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Breakthrough injection cuts bad cholesterol when pills Aren't enough
Disease control CompletedThis study tested whether adding a new injection called SAL003 to standard cholesterol pills helps lower bad cholesterol more effectively. The trial involved 720 Chinese adults with high cholesterol who weren't reaching target levels despite taking their regular medication. Parti…
Phase: PHASE3 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC